Literature DB >> 12809942

Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type.

Yutaka Nakashima1, Osamu Nakashima, Masatoshi Tanaka, Koji Okuda, Miwako Nakashima, Masamichi Kojiro.   

Abstract

Background/AIMS: Recurrence due to clinically undetectable intrahepatic metastasis and portal vein invasion of HCC cells is not 'uncommon' even in small HCCs. The present study investigated the relationship between these factors and macroscopic types of HCC.
METHODS: Surgically resected 209 cases of small HCC less than 3 cm in diameter were examined. Macroscopically, 209 cases were divided into 'vaguely nodular type', 'single nodular type', 'single nodular type with extranodular growth' and 'confluent multinodular type'.
RESULTS: None of the vaguely nodular type had intrahepatic metastasis or portal vein invasion, and their diameter was significantly smaller than the other three types. 'Single nodular type with extranodular growth' and 'confluent multinodular type' show higher frequency of portal vein invasion and intrahepatic metastases than 'single nodular type'. Among 149 metastatic lesions, the distance was 10 mm or shorter in 118 (79.2%).
CONCLUSIONS: It is important to precisely determine the gross type of small HCC by diagnostic imaging in order to predict portal vein invasion and micrometastasis. It is also important to ablate the tumor with enough surrounding tissue 1 cm in width at least to prevent the recurrence from those micrometastasis.

Entities:  

Year:  2003        PMID: 12809942     DOI: 10.1016/s1386-6346(03)00007-x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  60 in total

1.  Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.

Authors:  Mariya L Samoylova; Jennifer L Dodge; Neil Mehta; Francis Y Yao; John P Roberts
Journal:  Clin Transplant       Date:  2014-12-01       Impact factor: 2.863

2.  Microvascular invasion in hepatocellular carcinoma.

Authors:  Emre Ünal; İlkay Sedakat İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

Review 3.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

4.  Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study.

Authors:  Zhi Li Wang; Ping Liang; Bao Wei Dong; Xiao Ling Yu; De Jiang Yu
Journal:  J Gastrointest Surg       Date:  2007-10-18       Impact factor: 3.452

5.  Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?

Authors:  Honsoul Kim; Mi-Suk Park; Jin Young Choi; Young Nyun Park; Myeong-Jin Kim; Kyung Sik Kim; Jin Sub Choi; Kwang-Hyub Han; EunJu Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

6.  Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda; Seiji Okuda; Katsuhiko Otobe; Kenichi Takahashi
Journal:  Eur Radiol       Date:  2014-06-22       Impact factor: 5.315

7.  Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Seiji Okuda; Sadanobu Ogawa; Takumi Igura; Yasuharu Imai
Journal:  J Gastroenterol       Date:  2014-02-22       Impact factor: 7.527

Review 8.  Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

9.  Small hypervascular hepatocellular carcinomas: value of "washout" on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging.

Authors:  Jeong-Sik Yu; Jae-Joon Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-06-10       Impact factor: 5.315

10.  Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma.

Authors:  Jong Man Kim; Choon Hyuck; David Kwon; Jae-Won Joh; Joon Hyeok Lee; Seung Woon Paik; Cheol Keun Park
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.